Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adding Dexmedetomidine to Mannitol to Attenuate the Increase of Intracranial Pressure
NCT07064720Phase 3Completed
- Sponsor
- Cairo University
- Start
- Jul 2024
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dexmedetomidine in intracranial hypertension (IH), sponsored by Cairo University. Started Jul 2024; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
intracranial hypertension (IH)
Beyond the preview
Go deeper on NCT07064720.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07064720.